UBS’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$23K Buy
3,357
+271
+9% +$2.02K ﹤0.01% 7816
2014
Q2
$26K Sell
3,086
-205
-6% -$1.6K ﹤0.01% 7730
2014
Q1
$27K Sell
3,291
-1,393
-30% -$11.1K ﹤0.01% 7687
2013
Q4
$37K Buy
4,684
+770
+20% +$5.96K ﹤0.01% 7353
2013
Q3
$26K Sell
3,914
-249
-6% -$1.69K ﹤0.01% 7713
2013
Q2
$27K Buy
+4,163
New +$26.2K ﹤0.01% 7510

Other funds holding LMAT

UBS's LMAT Position: Q3 2014 in Review

UBS increased its LeMaitre Vascular (LMAT) stake by 8.8% in Q3 2014, buying an estimated $2.02K and bringing the position to 3,357 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #7816.

UBS first reported a position in LMAT in Q2 2013 and has held it in 6 quarters since. The position peaked at $37K in Q4 2013. 41 funds tracked by Wall St. Rank hold LMAT as of Q3 2014.

  • UBS held 3,357 shares of LeMaitre Vascular worth $23K as of Q3 2014.
  • UBS bought 271 LeMaitre Vascular shares in Q3 2014, an estimated $2.02K.
  • LeMaitre Vascular made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7816 holding.
  • UBS first reported a position in LeMaitre Vascular in Q2 2013 and has held it in 6 quarters since.
  • UBS's LeMaitre Vascular position peaked at $37K in Q4 2013.
  • 41 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.